Methods for reducing complexity of nucleic acid samples

• US 20020164634A1
• Filed: 04/24/2002
• Published: 11/07/2002
• Est. Priority Date: 08/26/2000
• Status: Abandoned Application

• Current Assignee: Perlegen Sciences, Inc.
• Original Assignee: Perlegen Sciences, Inc.
• Inventors: Patil, Nila, Cox, David R., Pethiyagoda, Charit, Frazer, Kelly A.
• Application Number:
  US10/131,832
• Publication Number:
  US 20020164634A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12N 15/101 by chromatography, e.g. electrophoresis, ion-exchange, reverse phase

Abstract

The invention provides several methods for reducing the complexity of a population of nucleic acids prior to performing an analysis of the nucleic acids on a nucleic acid probe array. The methods result in a subset of the initial population enriched for a desired property, or lacking nucleic acids having an undesired property. The resulting nucleic acids in the subset are then applied to the array for various types of analysis. The methods are particularly useful for analyzing populations having a high degree of complexity, for example, chromosomal-derived DNA, or whole genomic DNA, or mRNA population. In addition, such methods allow for analysis of pooled samples.

Claims

1. A method of analyzing a subset of nucleic acids within a nucleic acid population, comprising:

(a) providing a population of single-stranded nucleic acid fragments wherein at least some of said fragments have sequences that are repeated;

(b) incubating said population of nucleic acid fragments under conditions to produce a double-stranded subset of said population of nucleic acid fragments and a single-stranded subset of said population of nucleic acid fragments, wherein under said incubating conditions nucleic acid fragments of said population having repeat sequences preferentially anneal with each other relative to nucleic acid fragments of said population lacking repeat sequences;

(c) separating said single-stranded subset from said double-stranded subset;

(d) hybridizing said separated single-stranded subset to probes on a microarray; and

(e) determining which of said probes on said array hybridize to said single-stranded subset, thereby analyzing said single-stranded subset of said population of nucleic acid fragments.

2. The method of claim 1, wherein said population of nucleic acid fragments is genomic DNA.

3. The method of claim 2, wherein said genomic DNA is from a plurality of individuals.

4. The method of claim 1, wherein said population of nucleic acids is from a human genome.

5. The method of claim 1, wherein said separating step is performed by column chromatography.

6. The method of claim 5, wherein said column is a hydroxyapatite column.

7. The method of claim 6, wherein said separating step is performed under conditions whereby said single-stranded subset and said double-stranded are eluted in phosphate buffer.

8. The method of claim 1, wherein said separating step is performed by HPLC.

9. The method of claim 1, wherein said separating step is performed by successively performing hydroxyapatite chromatography and HPLC.

10. The method of claim 1, wherein said microarray comprises a set of probes complementary to a known reference sequence, said reference sequence being substantially identical to a sequence of said population of nucleic acid fragments.

11. The method of claim 10, wherein said population of nucleic acid fragments comprises a chromosome from a first individual, and said reference sequences is from a corresponding chromosome from a second individual.

12. The method of claim 10, wherein said population of nucleic acid fragments are genomic fragments from a first individual, and said reference sequence comprises genomic fragments from a second individual of a species closely related to said first individual.

13. The method of claim 10, wherein said population of nucleic acid fragments are genomic fragments from a non-human primate, and said reference sequence is from a human.

14. The method of claim 10, wherein said population of nucleic acid fragments are genomic fragments from a non-human mammal, and said reference sequence is from a human.

16. The method of claim 15, wherein said driver population of nucleic acids each bear a tag by which said driver population of nucleic acids can be immobilized via a binding moiety with affinity for said tag.

17. The method of claim 16, wherein said tag is biotin, and said binding moiety is avidin or streptavidin.

18. The method of claim 17, wherein said separating step is performed by immobilizing said driver population of nucleic acids via said tags on said driver population.

19. The method of claim 15, wherein said driver population of nucleic acids are genomic DNA from a first source, and said tester population of nucleic acids are genomic DNA from a second source.

20. The method of claim 19, wherein said first source is from a tissue of a first species, and said second source is from a same tissue of a different species.

21. The method of claim 19, wherein said first source is from a first tissue of a first species, and said second source is from a different tissue of said first species.

22. The method of claim 15, wherein said immobilizing step is performed before said annealing step.

23. The method of claim 15, wherein said immobilizing step is performed before said denaturing step.

24. The method of claim 15, wherein said driver population of nucleic acids is cDNA, and wherein sadi cDNA is incubated with C_0t1 DNA prior to said annealing step.

26. The method of claim 25, wherein said driver population is a population of genomic DNA fragments, and said tester population is mRNA or nucleic acids derived therefrom.

27. The method of claim 25, wherein said driver population is a population of genomic DNA fragments from a first source, and said tester population is genomic DNA from a second source.

28. The method of claim 27, wherein said tester population is from a genome of a first individual, and said driver population is from a genome of a different individual of a same species as said first individual.

29. The method of claim 27, wherein said tester population is from a genome of a first individual, and said driver population is from a genome of an individual of a different species than said first individual.

30. The method of claim 25, wherein either said driver population or said tester population or both said driver and said tester populations is a PCR amplification product.

31. The method of claim 25, wherein said driver population is a PCR amplification product and said tester population is genomic DNA.

32. The method of claim 31, wherein said genomic DNA is from more than one individual.

33. The method of claim 31, wherein said PCR amplification product is a long-range PCR amplification product.

34. The method of claim 31, wherein said tester population is subject to at least one amplification reaction.

35. The method of claim 34, wherein said amplification reaction is performed prior to step (a) or after said separating step.

36. The method of claim 25, wherein said driver population is from a plurality of noncontiguous regions of a genome of a species.

37. The method of claim 36, wherein said driver population is from at least ten noncontiguous regions.

38. The method of claim 25, wherein said driver population is mRNA or nucleic acids derived therefrom, and said tester population is genomic DNA.

39. The method of claim 25, wherein said driver population is mRNA or nucleic acids derived therefrom from a first source, and said tester population is mRNA or nucleic acids derived therefrom from a second source.

40. The method of claim 39, wherein said first source is from a tissue of a first species, and said second source is from a same tissue of a different species.

41. The method of claim 39, wherein said first source is from a first tissue of a first species, and said second source is from a different tissue of said first species.

42. The method of claim 25, wherein said immobilizing step is performed before said annealing step.

43. The method of claim 25, wherein said immobilizing step is performed before said first denaturing step.

44. The method of claim 25, wherein said driver population of nucleic acids each bear a tag by which said driver population can be immobilized to a binding moiety with affinity for said tag.

45. The method of claim 44, wherein said first separating step is performed by immobilizing said driver population of nucleic acids and tester population of nucleic acids hybridized to said driver population via said tags on said driver population.

15. A method of analyzing a subset of nucleic acids within a nucleic acid population, comprising:

(a) providing a single-stranded driver population of nucleic acids and a single-stranded tester population of nucleic acids;

(b) annealing said driver population of nucleic acids to said tester population of nucleic acids;

(c) immobilizing said driver population of nucleic acids;

(d) separating said unimmobilized subset of nucleic acids from said immobilized nucleic acids;

(e) hybridizing said unimmobilized subset of nucleic acids to probes on a microarray; and

(f) determining which of said probes on said microarray hybridize to said unimmobilized subset of nucleic acids, thereby analyzing said unimmobilized subset of nucleic acids.

25. A method of analyzing a subset of nucleic acids within a nucleic acid population, comprising:

(a) providing a single-stranded driver population of nucleic acids and a single-stranded tester population of nucleic acids;

(b) annealing said driver population of nucleic acids to said tester population of nucleic acids;

(c) immobilizing said driver population of nucleic acids;

(d) separating said unimmobilized nucleic acids from said immobilized nucleic acids;

(e) dissociating tester nucleic acids annealed to immobilized driver nucleic acids to produce a subset of complementary tester nucleic acids;

(f) separating said subset of complementary tester nucleic acids from said immobilized driver nucleic acids;

(g) hybridizing said subset of complementary tester nucleic acids to probes on a microarray;

(h) determining which of said probes on said microarray hybridize to said subset of complementary tester nucleic acids, thereby analyzing said subset of complementary tester nucleic acids.